Phreesia (PHR) Projected to Post Earnings on Monday

Phreesia (NYSE:PHR) is anticipated to announce its Q4 2026 results after the market closes on Monday, March 30th. Analysts expect Phreesia to post earnings of $0.0657 per share and revenue of $126.75 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2026 earning report page for the latest details on the call scheduled for Monday, March 30, 2026 at 5:00 PM ET.

Phreesia Trading Up 0.9%

PHR stock opened at $11.88 on Monday. Phreesia has a 52-week low of $10.75 and a 52-week high of $32.76. The company has a quick ratio of 2.44, a current ratio of 2.44 and a debt-to-equity ratio of 0.01. The firm has a market cap of $715.94 million, a P/E ratio of -118.74 and a beta of 0.67. The company’s 50-day simple moving average is $13.12 and its 200-day simple moving average is $18.35.

Insider Buying and Selling at Phreesia

In other news, insider Evan Roberts sold 6,317 shares of the firm’s stock in a transaction that occurred on Thursday, January 8th. The stock was sold at an average price of $17.01, for a total value of $107,452.17. Following the transaction, the insider owned 834,632 shares in the company, valued at $14,197,090.32. This trade represents a 0.75% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Balaji Gandhi sold 8,009 shares of Phreesia stock in a transaction that occurred on Thursday, January 8th. The stock was sold at an average price of $17.01, for a total value of $136,233.09. Following the completion of the sale, the chief financial officer directly owned 156,231 shares in the company, valued at $2,657,489.31. This represents a 4.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 60,353 shares of company stock valued at $1,006,528. 5.50% of the stock is owned by insiders.

Institutional Investors Weigh In On Phreesia

Large investors have recently modified their holdings of the business. Prosight Management LP purchased a new position in shares of Phreesia in the fourth quarter worth about $16,533,000. Millennium Management LLC boosted its position in Phreesia by 730.7% during the third quarter. Millennium Management LLC now owns 1,064,132 shares of the company’s stock worth $25,028,000 after acquiring an additional 936,033 shares during the last quarter. Jacobs Levy Equity Management Inc. purchased a new stake in Phreesia during the 4th quarter valued at about $15,213,000. JPMorgan Chase & Co. grew its stake in Phreesia by 807.7% during the 4th quarter. JPMorgan Chase & Co. now owns 507,220 shares of the company’s stock valued at $8,582,000 after acquiring an additional 451,339 shares in the last quarter. Finally, Franklin Resources Inc. raised its holdings in Phreesia by 28.8% in the 4th quarter. Franklin Resources Inc. now owns 2,000,082 shares of the company’s stock valued at $33,841,000 after acquiring an additional 446,890 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Citigroup lowered their price target on Phreesia from $29.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday, January 9th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Phreesia in a research note on Wednesday, January 28th. Mizuho set a $22.00 target price on Phreesia in a research report on Wednesday, February 4th. DA Davidson dropped their price target on shares of Phreesia from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Friday, January 23rd. Finally, Robert W. Baird cut their price target on shares of Phreesia from $31.00 to $25.00 and set an “outperform” rating for the company in a report on Wednesday, December 10th. Seventeen research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.12.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.